Bengaluru (Karnataka) [India]/ Saratoga (California) [US]/ Adelaide [Australia], November 8 (ANI/PRNewswire): Bugworks research today announced that the first human dose was administered in a Phase 1 clinical trial evaluating BWC0977: a next generation broad-spectrum, novel bacterial topoiso